Universal Vision Biotechnology Co., Ltd. (TPEX: 3218)

Market Cap	16.94B
Revenue (ttm)	4.18B
Net Income (ttm)	1.08B
Shares Out	84.72M
EPS (ttm)	12.70
PE Ratio	15.75
Forward PE	15.24
Dividend	7.00 (3.50%)
Ex-Dividend Date	n/a

Volume	54,962
Open	205.50
Previous Close	206.50
Day's Range	202.50 - 205.50
52-Week Range	200.50 - 307.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 28, 2025

About Universal Vision Biotechnology

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses fo...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1992
• Employees: 401
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3218

Financial Performance

In 2023, Universal Vision Biotechnology's revenue was 4.08 billion, an increase of 16.83% compared to the previous year's 3.49 billion. Earnings were 1.05 billion, an increase of 22.88%.